Annunziata Dattola | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Tildrakizumab and Quality of Life: Deep Dive into the Impact of Psoriasis and Treatment on Different Domains—Should Psychosocial Life Impairment Be Considered a Comorbidity?	JOURNAL OF CLINICAL MEDICINE	2025
Effectiveness, speed of action and safety of brodalumab in elderly psoriasis patients: a multicenter real-world study–IL PSO (Italian Landscape Psoriasis)	JOURNAL OF DERMATOLOGICAL TREATMENT	2025
Treating psoriatic arthritis in the early phase: proposal for a shared dermatological and rheumatological therapeutic intervention with biologics and targets synthetic disease-modifying immunosuppressive drugs	ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY	2025
Risankizumab versus Secukinumab: a real-world efficacy and cost per responder comparison in patients with psoriasis in Italy	DERMATOLOGY PRACTICAL & CONCEPTUAL	2025
Efficacy and safety of tildrakizumab in elderly patients. Real-world multicenter study (ESTER - study)	JOURNAL OF DERMATOLOGICAL TREATMENT	2024
Dupilumab as therapeutic option in polysensitized atopic dermatitis patients suffering from food allergy	NUTRIENTS	2024
Interleukin-13 inhibitors in the treatment of atopic dermatitis. the role of tralokinumab	DERMATOLOGY PRACTICAL & CONCEPTUAL	2024
Efficacy and safety of intra-class switching from Ixekizumab to Secukinumab in patients with plaque psoriasis. A multicenter retrospective study	JOURNAL OF PERSONALIZED MEDICINE	2024
Diagnosing psoriatic arthritis in the early phase: what factors should dermatologists consider for an appropriate referral of patients with psoriasis to rheumatologists	ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY	2024
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study	JOURNAL OF DERMATOLOGICAL TREATMENT	2024
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study. IL PSO (Italian Landscape Psoriasis)	JOURNAL OF DERMATOLOGICAL TREATMENT	2024
"Super long-term" response in a psoriatic patient after discontinuation of Bimekizumab. is there a new possibility for the management of chronic plaque psoriasis	ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY	2024
The role of guselkumab in psoriatic artrithis and disease progression in patients with confirmed diagnosis of enthesitis	ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY	2024
Anti-herpes zoster vaccination in patients with dermatologic diseases. a position statement from the iItalian SIDeMaST group of sexually transmitted, infectious and tropical diseases	ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY	2024
TikTok in dermatology. experience on a potent social media for empowering education in dermatology in young generations	ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY	2024
Effect of baricitinib in patients with alopecia areata: usefulness of trichoscopic evaluation	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY	2024
Spesolimab in patients with flare of generalized pustular psoriasis. a multicentre case-series	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY	2024
Awareness of obesity among patients with psoriasis	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY	2024
Bimekizumab for the Treatment of Plaque Psoriasis with Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis)	DERMATOLOGY PRACTICAL & CONCEPTUAL	2024
Therapeutic therapeutic potential of spesolimab-sbzo in the management of generalized pustular psoriasis flares in adults. evidence to date	PSORIASIS	2024